SPECT · Amen
Blood flow and activity. What is working, working too hard, or running low. That page stays the blood-flow view.
SPECT showed blood flow. QEEG showed rhythm. This is the third view — the genomic panel I was issued, read through IntellxxDNA, and translated the same way as the scans: technical finding first, then how it shows up. None of what follows is a prescription for you. It is mine.
The knocks came later. The two machines looked at what my brain is doing now. This panel is older than both of those stories — it is the starting kit. I wanted it in the same walk-through, in the same voice.
Blood flow and activity. What is working, working too hard, or running low. That page stays the blood-flow view.
Electrical rhythm. What the cortex is doing, band by band, against an age-matched map. That page stays the rhythm view.
A licensed provider ordered the panel and read it as clinical decision support — one input next to history, exam, and labs. I am not naming that person on this page until they have given written permission. The report is not a diagnosis. These are small DNA changes that by themselves are not disease-causing. They can matter as they interact with each other and with diet, lifestyle, and environment.
The rest of the report can wait in the spokes. These six are the ones that moved the daily stack, the avoid list, or a standing instruction.
Several independent rows pointed the same direction. That is why I did not pick a favorite intervention.
That is the catecholamine story, and it sits under anxiety, rumination, attention, and stimulant response at once.
Receptor rows stacked on top of the clearance hub. The practical read-through is skepticism about a few common levers, not a diagnosis.
That is the highest-stakes practical finding. It belongs on its own spoke, not buried in a table.
Nutrient status is the clean example. The same logic runs through several mineral and vitamin rows.
Pharmacogenomics is where the report is most usable. The standing instruction is still: notify the anesthesiologist.
DNA is the starting kit. It does not move. SPECT and QEEG can. Until I have a reviewed overlap matrix, I am not inventing agreement. The three-tests spoke keeps the conflicts visible.
None of this is a prescription for you — it is mine. Dosages live on the spokes that own those rows. Verify with your own clinician before copying any of it.
A clot-support enzyme, magnesium threonate, omega-3s, sulforaphane, velvet bean, and vitamin B6. Each one is tied to a printed row, not to a vibe.
Coffee and an earlier dinner sit next to a low-sugar tilt and high-magnesium / high-B12 foods. Glyphosate, smoke, and quercetin caution sit on the other side. Meditation is the lifestyle line.
A genetics page that presents itself as certain is dishonest. That is the most important line on this hub.
“The report contains internal conflicts and does not hide them. I am leaving those fights on the page instead of picking a winner.”
Kevin Meuret · first person, from the panel
IntellxxDNA describes itself as a clinical decision-support tool for licensed providers — one input next to a full history, an exam, and labs — not something meant to diagnose or treat illness on its own. Nothing on this page is a diagnosis.
The hub stays short on purpose. The genotypes, tables, and caveats live one level down.
The two doctors’ pages sit next. Same brain, two more instruments.
Next: both practitioners' recommendations in one daily routine.
Next: Protocol